Activity
Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors
Pacira BioSciences; Samit Hirawat; Board of Directors; appointment; non-opioid pain therapies
Convergent Therapeutics Appoints Elizabeth L. Montgomery as Chief People Officer
Convergent Therapeutics; Elizabeth Montgomery; CPO; biotechnology; radiopharmaceuticals; appointment
QIAGEN Appoints Mark Stevenson to Supervisory Board
QIAGEN; Mark Stevenson; Supervisory Board; appointment; life sciences
Orphan Drug Trends: A Data-Driven Analysis
orphan drugs; market growth; rare diseases; FDA approvals; genomics; reimbursement challenges
Erasca, Corvus, and BioAge Target $500M+ Offerings Amid Biotech Fundraising Surge
Erasca; Corvus; BioAge; biotech offerings; fundraising; public offering
Angelini Pharma Appoints Sergio Marullo di Condojanni as New CEO
Angelini Pharma; Sergio Marullo di Condojanni; CEO Appointment; Angelini Industries
FDA Lifts Partial Hold on Merck and Daiichi Sankyo’s B7-H3 ADC Trial for Lung Cancer[6]
FDA; partial hold lifted; Merck; Daiichi Sankyo; ifinatamab deruxtecan; I-DXd; B7-H3 ADC; small cell lung cancer; IDeate-Lung02
Dr Melanie Ivarsson Appointed CEO of Health Data Research Service
Dr Melanie Ivarsson; Health Data Research Service; HDRS; CEO appointment; UK health data; medical research
Syncromune Appoints Dr. Stephen P. Dale as Chief Medical Officer
Syncromune; Stephen P. Dale; CMO; appointment; oncology; SYNC-T; biopharmaceutical
Avicanna Announces Changes to its Board of Directors
Avicanna; board changes; Michael Kott; Paul Fornazzari; appointment; resignation